MACGALIN
SR
For the use of a Registered Medical
Practitioner or a Hospital or a Laboratory
Abbreviated Prescribing information
for MACGALIN SR (Pregabalin Sustained Release 75 mg and
Methylcobalamin 1500 mcg)
[Please refer the complete prescribing
information available at www.macnispharma.com]
PHARMACOLOGICAL PROPERTIES: Pregabalin: binds with high affinity to the
alpha 2-delta site (an auxiliary subunit of voltage-gated calcium channels) in
central nervous system tissues which, may be involved in antinociceptive and
antiseizure effects. Vitamin B12 is required for synthesis of deoxyri bonucleic
acid (DNA).
INDICATION:
For painful neuropathies such as: Diabetic neuropathy, Postherpetic neuralgia,
Trigeminal neuralgia, Following nerve entrapment as in prolapsed intervertebral
disc, Complex regional pain syndrome, Infective neuropathies, HIV sensory
neuropathy, Alcoholic neuropathy, Nutritional neuropathies, Phantom limb pain.
DOSAGE
AND ADMINISTRATION: Adults: Once daily with/without food. Dosage above 300
mg/day must be reserved only for those having on-going pain, and tolerating
300mg pregabalin per day. Renal dysfunction (maximum dose): Creatinine
clearance 30-60 ml/min- 300 mg/day, Creatinine clearance 15-30 ml/min- 150
mg/day, Creatinine clearance <15 ml/min- 75 mg/day.
CONTRAINDICATION:
MACGALIN SR is not advocated to those
hypersensitive to the drug or to any of its ingredients.
WARNINGS
& PRECAUTIONS: MACGALIN SR must not
be discontinued abruptly due to the possibility of increasing seizure
frequency; rapid discontinuation may also result in insomnia, nausea, headache,
or diarrhea. Since pregabalin can cause dizziness, somnolence and other
manifestations of central nervous system depression, patients should be advised
neither to drive nor to operate complex machinery until they have gained
sufficient experience on MACGALIN SR . If vision disturbances occur during
pregabalin therapy, medical advice must be sought. MACGALIN SR must be advocated with caution in heart
failure and diabetic patients in view of possibility of edema and weight gain.
Diabetic patients taking pregabalin may develop skin ulcerations. MACGALIN SR must be advocated with due precaution in renal
dysfunction. Those with early Leber's disease when treated with vitamin B12 can
suffer from severe and swift optic atrophy. MACGALIN SR should be used during pregnancy and lactation
only if the potential benefit justifies the probable risks involved.
DRUG
INTERACTION: Gabapentin may slightly decrease the rate of absorption of
pregabalin when administered together.
ADVERSE
REACTIONS: Dizziness, somnolence, dry mouth, edema, blurred vision, weight
gain, “thinking abnormal”, asthenia, ataxia, abnormal gait, paresthesias,
diplopia, visual field defect, nystagmus, nausea, tremor, vertigo, headache,
nervousness, confusion, edema, abdominal pain, allergic reaction, fever, flu
syndrome, accidental injury, gastroenteritis, diarrhea, flatulence, increased
appetite, constipation, ecchymosis; peripheral edema, arthralgia, leg cramps,
myalgia, myasthenia, nervousness, amnesia, speech disorder, incoordination,
abnormal gait, confusion, anxiety, depersonalization, hypertonia, hypesthesia,
libido decreased, nystagmus, paresthesia, stupor, twitching, euphoria,
bronchitis, dyspnea, pruritus, face swelling, conjunctivitis, diplopia,
abnormal vision, otitis media, tinnitus, anorgasmia, impotence, urinary
frequency, urinary incontinence, pulmonary edema, congestive heart failure, peripheral vascular thrombosis, polycythemia
vera, mild transient diarrhea itching, transitory exanthema, feeling of
swelling of entire body.
MARKETED
BY:
MACNIS PHARMACEUTICALS
J3/31 A-3,3rd
Floor,Khiri Extension.
Malviya Nagar,New Delhi-17
Visit us at: www.macnispharma.com
Reach us at: info@macnispharma.com